2023 - 2023

FUROSCIX®

FUROSCIX Launch

  • Launch and Commercial Availability of FUROSCIX® (furosemide injection)
  • Positive Type C Meeting Feedback from FDA on Potential Heart Failure Class IV Indication Expansion

scPharmaceuticals is now part of MannKind. We’re excited about this new chapter and what it means for our team, partners, and patients.

Visit MannKind

scPharmaceuticals is now part of MannKind. We’re excited about this new chapter and what it means for our team, partners, and patients.

Visit MannKind

scPharmaceuticals is now part of MannKind. We’re excited about this new chapter and what it means for our team, partners, and patients.

Visit MannKind